HCA · HCA Healthcare, Inc.
$382.21
+5.71 (+1.52%)
At close · Jul 24
Market Cap
$84.78B
Shares
221.84M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Samuel Hazen | CEO | $26,456,606 |
| Jon M. Foster | COO | $10,992,786 |
| Michael A. Marks | CFO | $10,355,111 |
| Michael R. McAlevey | Executive Vice President – Chief Legal and Administrative Officer | $5,710,335 |
| Michael S. Cuffe | Executive Vice President and Chief Clinical Officer | $5,704,197 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Samuel Hazen | CEO | $23,799,137 |
| Jon M. Foster | COO | $9,170,258 |
| Michael R. McAlevey | Executive Vice President – Chief Legal and Administrative Officer | $5,738,785 |
| Michael S. Cuffe | Executive Vice President and Chief Clinical Officer | $5,541,299 |
| Michael A. Marks | CFO | $5,509,371 |
| William Rutherford | CFO | $4,647,765 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Samuel Hazen | CEO | $21,315,984 |
| Jon M. Foster | COO | $8,699,360 |
| William Rutherford | CFO | $7,763,050 |
| Timothy M. McManus | President — National Group | $5,582,431 |
| Erol R. Akdamar | President — American Group | $5,400,861 |
| Michael R. McAlevey | Executive Vice President – Chief Legal and Administrative Officer | $4,722,821 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Samuel Hazen | CEO | $14,637,726 |
| Michael R. McAlevey | Executive Vice President – Chief Legal and Administrative Officer | $6,465,633 |
| William Rutherford | CFO | $5,058,078 |
| Charles J. Hall | President — National Group | $4,996,051 |
| Jon M. Foster | COO | $4,148,211 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Samuel N | CEO | $20,635,260 |
| Samuel Hazen | CEO | $20,635,260 |
| William Rutherford | CFO | $7,163,022 |
| Jon M. Foster | COO | $6,046,102 |
| Charles J. Hall | President — National Group | $5,631,206 |
| Michael S. Cuffe | Executive Vice President and Chief Clinical Officer | $5,157,924 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Samuel Hazen | CEO | $30,397,771 |
| Samuel N | CEO | $30,397,771 |
| Jon M. Foster | Executive Vice President and Chief Operating Officer | $8,556,247 |
| Charles J. Hall | President — National Group | $6,971,868 |
| Jonathan B. Perlin | President — Clinical Services Group and Chief Medical Officer | $6,502,366 |
| William Rutherford | CFO | $6,134,778 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Samuel N | CEO | $26,788,251 |
| Jon M. Foster | Executive Vice President and Chief Operating Officer | $7,761,079 |
| Charles J. Hall | President — National Group | $6,508,152 |
| William Rutherford | CFO | $6,323,179 |
| Jonathan B. Perlin | President — Clinical Services Group and Chief Medical Officer | $5,991,256 |
| R. Milton Johnson | Chairman | $4,313,240 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| R. Milton Johnson | Chairman | $21,419,906 |
| Samuel N | CEO | $10,006,950 |
| William Rutherford | CFO | $6,801,384 |
| Jon M. Foster | Executive Vice President and Chief Operating Officer | $4,531,843 |
| Charles J. Hall | President — National Group | $4,149,792 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| R. Milton Johnson | Chairman | $17,268,724 |
| Samuel N | CEO | $9,529,878 |
| William Rutherford | CFO | $4,936,024 |
| Jon M. Foster | Executive Vice President and Chief Operating Officer | $4,209,958 |
| Charles J. Hall | President — National Group | $3,011,921 |
Key facts
CIK
860730
CUSIP
40412C101
13F (30d)
346 filings
342 filers
Visit website
Investor relations